VapoJect®︎: A High-Certainty Business Opportunity with a 2-Year Path to IPO
The Engine for Exponential Growth, Powered by an Approved Platform Technology.
“VapoJect®︎” is the next strategic phase of the STONY ecosystem and the “killer application” that will drive our corporate value. This report details how we will leverage our rock-solid foundation of a regulatory-approved core component to achieve high growth and target an Initial Public Offering (IPO) in two years.
Clear Exit Strategy
IPO in 2 Years
Current Pre-Money Valuation
JPY 1-2 Billion
De-Risked Business
PMDA-Approved Platform
The Foundation: An Approved Ventilator Business
The core power source, our pneumatic ventilator, is already approved as a Class III medical device. Its imminent market launch will establish a stable revenue base and market credibility.
The Growth Engine: VapoJect®︎
Upon this solid foundation, we will deploy VapoJect®︎ as a high-value option. Up-selling through system bundles will dramatically increase the company’s overall profitability and growth.